Clinical Trials Logo

Clinical Trial Summary

- Parasitic infection is a serious public health problem throughout the world particularly in developing countries including Egypt. The individuals infected with helminths are responding to the parasite infections by a specific Th2 type innate and adaptive immune responses. The Coronavirus Disease 2019 pandemic has affected over 169 million people and caused the death of millions worldwide. COVID vaccines with up to 95% of efficacy and effectiveness have been developed and approved by the Food and Drug Administration (FDA), USA. Moreover, it's reported that vaccination against COVID may lead to Cytokine Storm Syndrome in some vaccinated people with release of large amounts of cytokines as (IFNγ, IL-12, TNFα).


Clinical Trial Description

- Parasitic infection is a serious public health problem throughout the world particularly in developing countries including Egypt. - Stool examination and CBC(complete blood count) are considered as the most easily, affordable and accessible diagnostic tool to suspect the presence of parasitic infection. - One of the most important laboratory findings in many helminthic and protozoan infections is the high rate of peripheral blood eosinophilia. Giardia lamblia cause increased number of lymphocytes. - The individuals infected with helminths are responding to the parasite infections by a specific Th2 type innate and adaptive immune responses. The Th2 pattern cytokines predominate in long-term helminth infected individuals. - During chronic helminths infection, there is increased production of interleukin-4 (IL-4) and interleukin-10 (IL-10) as anti-inflammatory cytokines, as well as increased activation and expansion of eosinophils, mast cells and basophils. - In addition, IFNγ have an important inflammatory role in many protozoan parasites as Cryptosporidium, Microsporidia, Entamoeba histolytica. - The Coronavirus Disease 2019 pandemic has affected over 169 million people and caused the death of millions worldwide. COVID vaccines with up to 95% of efficacy and effectiveness have been developed and approved by the Food and Drug Administration (FDA), USA. - Moreover, it's reported that vaccination against COVID may lead to Cytokine Storm Syndrome in some vaccinated people with release of large amounts of cytokines as (IFNγ, IL-12, TNFα). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05185778
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date April 1, 2022
Completion date October 30, 2025

See also
  Status Clinical Trial Phase
Completed NCT00630162 - Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts N/A
Recruiting NCT06141057 - A Study to Compare Two Dosing Regimens for a New Malaria Vaccine Phase 1
Active, not recruiting NCT03173001 - Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis
Active, not recruiting NCT03441893 - Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis Phase 1/Phase 2
Completed NCT01533961 - Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 Phase 1
Completed NCT04310085 - Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites Phase 1
Recruiting NCT04694235 - Egg Intervention During Pregnancy in Indonesia N/A
Completed NCT05979207 - Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum Phase 1
Completed NCT05287893 - Pyronaridine in Healthy Adult Participants Infected With Blood Stage Malaria Phase 1
Completed NCT00511589 - Chagas Disease Diagnostic - Inconclusive Serology N/A
Completed NCT00002191 - A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis Phase 3